Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-009380

SVP, Chief Technical Officer acquired 8,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LaBarre Michael J. · SVP, Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-10-12 Exercise or conversion : show line 1 in the form +8,050 $13.10 $105,455 156,846 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-10-12 Exercise or conversion : show line 2 in the form Option to Purchase Common Stock −8,050 $13.10 2024-02-06 8,050 0 D
Loading xslF345X03/edgar.xml…